Riparian Pharmaceuticals Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Series A2
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 9

Riparian Pharmaceuticals General Information

Description

Developer of therapeutics designed to improve endothelial function to reduce vascular complications. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 201 Dexter Avenue
  • Watertown, MA 02472
  • United States
+1 (617) 000-0000

Riparian Pharmaceuticals Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Riparian Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A2) 01-Jun-2020 $3M 000 Completed Generating Revenue
6. Later Stage VC (Series A1) 12-Oct-2018 000 000 00.00 Completed Generating Revenue
5. Accelerator/Incubator 05-Oct-2017 Completed Generating Revenue
4. Accelerator/Incubator 13-Oct-2016 Completed Generating Revenue
3. Grant 06-Jun-2016 00000 Completed Generating Revenue
2. Grant 01-Jan-2016 $2.83M Completed Generating Revenue
1. Grant 01-Jan-2013 $857K Completed Startup
To view Riparian Pharmaceuticals’s complete valuation and funding history, request access »

Riparian Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
To view Riparian Pharmaceuticals’s complete cap table history, request access »

Riparian Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
William Adams Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Guillermo Garcia-Cardena Ph.D Co-Founder, Scientific Advisor & Collaborator
To view Riparian Pharmaceuticals’s complete executive team members history, request access »

Riparian Pharmaceuticals Board Members (2)

Name Representing Role Since
Michael Serrano-Wu Riparian Pharmaceuticals Board Member 000 0000
William Adams Ph.D Riparian Pharmaceuticals Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view Riparian Pharmaceuticals’s complete board members history, request access »

Riparian Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Riparian Pharmaceuticals Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JMCR Partners Venture Capital Minority 000 0000 000000 0
Sprout Bioventures Venture Capital Minority 000 0000 000000 0
Viva Biotech VC-Backed Company Minority 000 0000 000000 0
Harvard Innovation Launch Lab Accelerator/Incubator 000 0000 000000 0
Pagliuca Harvard Life Lab Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »